Could a new drug tame fatty liver disease? early trial aims to find out
Disease control
Recruiting now
This early-stage trial is testing an experimental drug called INI-822 to see if it is safe and tolerable. It involves healthy volunteers and people with MASH, a type of fatty liver disease. The study will give different doses of the drug or a placebo to see how the body handles i…
Phase: PHASE1 • Sponsor: Inipharm Australia Pty Ltd • Aim: Disease control
Last updated Aug 05, 2026 00:00 UTC